• Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy

      Elmarakby, Ahmed A.; Abdelsayed, Rafik; Yao Liu, Jun; Mozaffari, Mahmood S.; Department of Oral Biology (2010-03-13)
      Keywords: Renal disease
    • Endothelial dysfunction in diabetes: potential application of circulating markers as advanced diagnostic and prognostic tools

      Abebe, Worku; Mozaffari, Mahmood S.; Department of Oral Biology (2010-03-10)
      Keywords: Vascular disease
    • Effects of chromium picolinate on glycemic control and kidney of the obese Zucker rat.

      Mozaffari, Mahmood S.; Abdelsayed, Rafik; Liu, Jun Yao; Wimborne, Hereward J. C.; El-Remessy, Azza B.; El-Marakby, Ahmed; Department of Oral Biology; Department of Oral Health and Diagnostic Sciences (2009-12-30)
      ABSTRACT: BACKGROUND: Chromium picolinate (Cr(pic)3) is advocated as adjuvant therapy for impaired glycemic control, despite concerns for DNA damage. Potential toxicity of Cr(pic)3 should be greater for the kidney that accumulates chromium. Therefore, we tested the hypothesis that Cr(pic)3 treatment of obese Zucker rats (OZR) exacerbates renal abnormalities associated with dysglycemia. METHODS: Male OZR were treated with diets lacking or containing 5 and 10 mg/kg of chromium, as Cr(pic)3, for 20 weeks; lean Zucker rats (LZR) served as controls. Glycemic and renal effects of Cr(pic)3 were determined in the context of indices of oxidative stress and inflammation. RESULTS: The OZR displayed increased fasting plasma glucose and insulin in association with enlarged pancreatic islets exhibiting collagen and periodic acid Schiff-positive deposits compared to LZR; Cr(pic)3 treatment did not affect these parameters. The OZR, irrespective of Cr(pic)3, excreted more albumin than LZR. Also, other indices of renal function or histopathology were not affected by Cr(pic)3 treatment. Urinary excretion of 8-hydroxydeoxyguanosine (8-OHdG), an index of oxidative DNA damage, was greater in the OZR than LZR; dietary Cr(pic)3 treatment attenuated 8-OHdG excretion. However, immunostaining of kidney for 8-OHdG revealed similar staining pattern and intensity, despite significant renal accumulation of chromium in Cr(pic)3-treated groups. Finally, increased renal nitrotyrosine and cyclooxygenase-2 levels and urinary excretion of monocyte chemoattractant protein-1 of OZR were partially reversed by Cr(pic)3 treatment. CONCLUSION: Dietary Cr(pic)3 treatment of OZR does not beneficially influence glycemic status or increase the risk for oxidative DNA damage; rather, the treatment attenuates indices of oxidative stress and inflammation.